Guidance

Influenza vaccines marketed in the UK

Influenza vaccines marketed in the UK for 2024 to 2025 and 2025 to 2026, including ovalbumin content.

From:
UK Health Security Agency
Published
1 April 2022
Last updated
13 February 2025 — See all updates

Documents

All influenza vaccines marketed in the UK for the 2025 to 2026 season (text version)

HTML

All influenza vaccines marketed in the UK for the 2025 to 2026 season (print version)

PDF, 107 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

All influenza vaccines marketed in the UK for the 2024 to 2025 season (text version)

Ref: UKHSA gateway number 2024063

HTML

All influenza vaccines marketed in the UK for the 2024to 2025 season (print version)

Ref: UKHSA gateway number 2024063

PDF, 102 KB, 1 page

Details

This table lists all of the vaccines that are marketed in the UK for the 2024 to 2025 and 2025 to 2026 flu vaccination seasons, including ovalbumin content.

For information on the use of influenza vaccines in egg allergic individuals please see the green book influenza chapter 19.

Updates to this page

Published 1 April 2022
Last updated 13 February 2025 + show all updates

  1. Added 'All influenza vaccines marketed in the UK for the 2025 to 2026 season' text and print versions.

  2. Updated Viatris product field in tables (text and print).

  3. Updated tables (text and print).

  4. Updated 'All influenza vaccines marketed in the UK for the 2024 to 2025 season'.

  5. Updated for the 2024 to 2025 season.

  6. Updated tables (text and print).

  7. Updated table.

  8. First published.

Sign up for emails or print this page

Related content